Carsten Boltze
Department of Pathology
Otto-von-Guericke-University
Magdeburg
Germany
Name/email consistency: high
- Hypermethylation of the CDKN2/p16INK4A promotor in thyroid carcinogenesis. Boltze, C., Zack, S., Quednow, C., Bettge, S., Roessner, A., Schneider-Stock, R. Pathol. Res. Pract. (2003)
- Silencing of the maspin gene by promoter hypermethylation in thyroid cancer. Boltze, C., Schneider-Stock, R., Quednow, C., Hinze, R., Mawrin, C., Hribaschek, A., Roessner, A., Hoang-Vu, C. Int. J. Mol. Med. (2003)
- Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma. Boltze, C., Mundschenk, J., Unger, N., Schneider-Stock, R., Peters, B., Mawrin, C., Hoang-Vu, C., Roessner, A., Lehnert, H. J. Clin. Endocrinol. Metab. (2003)
- Intermuscular chondrolipoma of the thigh: the diagnostic way of a rare entity. Boltze, C., Hribaschek, A., Lippert, H., Roessner, A. Pathol. Res. Pract. (2003)
- Proteome analysis identified maspin as a special feature of papillary thyroid carcinoma. Boltze, C., Schneider-Stock, R., Quednow, C., Gerlach, R., Mawrin, C., Hinze, R., Roessner, A., Hoang-Vu, C. Int. J. Oncol. (2003)
- Maspin in thyroid cancer: its relationship with p53 and clinical outcome. Boltze, C., Schneider-Stock, R., Meyer, F., Peters, B., Quednow, C., Hoang-Vu, C., Roessner, A. Oncol. Rep. (2003)
- Function of HSP90 and p23 in the telomerase complex of thyroid tumors. Boltze, C., Schneider-Stock, R., Roessner, A., Quednow, C., Hoang-Vu, C. Pathol. Res. Pract. (2003)
- HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma. Boltze, C., Lehnert, H., Schneider-Stock, R., Peters, B., Hoang-Vu, C., Roessner, A. Endocrine (2003)
- CD97, CD95 and Fas-L clearly discriminate between chronic pancreatitis and pancreatic ductal adenocarcinoma in perioperative evaluation of cryocut sections. Boltze, C., Schneider-Stock, R., Aust, G., Mawrin, C., Dralle, H., Roessner, A., Hoang-Vu, C. Pathol. Int. (2002)
- Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma. Boltze, C., Roessner, A., Landt, O., Szibor, R., Peters, B., Schneider-Stock, R. Int. J. Oncol. (2002)
- Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature. Boltze, C., Schneider-Stock, R., Jäger, V., Roessner, A. Pathol. Res. Pract. (2001)
The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.








